Together, these results suggest that there is a tumour-cell autonomous inflammatory signal present in a subset of melanomas that may predispose the tumour to enhanced MHC-II expression, antigen presentation (direct or cross presentation via exosomes35) to CD4+ T-helper cells and immune recognition, coinciding with higher PD-L1 expression. The gene discussed is CD4; the disease is melanoma.